Global AIDS response will miss 2015 targets, ONE report suggests

"The world has lost momentum in the fight against the AIDS epidemic, with millions of new people infected last year, the ONE foundation said in a report," titled "The Beginning of the End? Tracking Global Commitments on AIDS" and released on Tuesday, Reuters reports. In its annual report last week, UNAIDS said despite advances in access to medicines that both treat and prevent HIV infection, 2.5 million new cases of HIV occurred in 2011, according to the news service. "That is more than double the target of having only 1.1 million people newly infected each year, said ONE," according to Reuters.

The ONE report "shows that although significant progress has been made, if we maintain the status quo on treatment and prevention, we won't see the beginning of the end of AIDS until 2022," Erin Hohlfelder, ONE's policy director for global health, writes in an article on the organization's webpage. "In 2013, global leaders will also discuss a new post-2015 global development framework," she states, adding, "Without scaled-up financing, more targeted programming and expanded political will, the beginning of the end of AIDS will remain a distant ambition" (11/27). "The ONE report examined funding for AIDS from the Group of Seven major developed countries, as well as the political leadership and strategy," Reuters writes, noting its release "comes ahead of World AIDS Day on December 1" (11/27).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative HIV vaccine approaches yield potential for broad protection against viral strains